These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11037743)

  • 21. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naratriptan in the short-term prophylaxis of pure menstrual migraine.
    Moschiano F; Allais G; Grazzi L; Usai S; Benedetto C; D'Amico D; Roncolato M; Bussone G
    Neurol Sci; 2005 May; 26 Suppl 2():s162-6. PubMed ID: 15926020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study.
    Stronks DL; Tulen JH; Bussmann HB; Mulder LJ; Passchier J
    Headache; 2003 Sep; 43(8):845-52. PubMed ID: 12940805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naratriptan.
    Massiou H
    Curr Med Res Opin; 2001; 17 Suppl 1():s51-3. PubMed ID: 12463278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 27. Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
    Rapoport AM; Bigal ME; Volcy M; Sheftell FD; Feleppa M; Tepper SJ
    Headache; 2003 May; 43(5):482-9. PubMed ID: 12752754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacy-clinic medication of the month. Naratriptan (naramig)].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):189-91. PubMed ID: 10321110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW
    Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
    Hewitt DJ; Pearlman E; Hämäläinen M; Lewis D; Connor KM; Michelson D; Ceesay P; Assaid C; Bachman R; Harper Mozley L; Dupre N; Strickler N; Mahoney E; Lines C; Ho TW
    Headache; 2013 Jan; 53(1):104-117. PubMed ID: 23078588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.
    Pascual J; Falk RM; Piessens F; Prusinski A; Docekal P; Robert M; Ferrer P; Luria X; Segarra R; Zayas JM
    Cephalalgia; 2000 Jul; 20(6):588-96. PubMed ID: 11075844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R
    Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract]   [Full Text] [Related]  

  • 36. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 37. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
    Sheftell FD; Rapoport AM; Tepper SJ; Bigal ME
    Headache; 2005; 45(10):1400-6. PubMed ID: 16324173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
    Zagami AS
    Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of migraine during prodrome with naratriptan.
    Luciani R; Carter D; Mannix L; Hemphill M; Diamond M; Cady R
    Cephalalgia; 2000 Mar; 20(2):122-6. PubMed ID: 10961768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.